Home Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
Article
Licensed
Unlicensed Requires Authentication

Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience

  • Elena Lazarova EMAIL logo , Béatrice Gulbis , Brigitte van Oirschot and Richard van Wijk
Published/Copyright: August 25, 2016
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 55 Issue 3

Abstract

Background:

Osmotic gradient ektacytometry is part of the laboratory diagnosis process of hereditary spherocytosis (HS) and other red blood cell (RBC) membrane disorders. We here present the experience of two independent institutions with a next-generation ektacytometer, the LoRRca MaxSis analyzer, in HS diagnostic settings.

Methods:

Inter- and intra-assay variability and sample stability were analyzed. Samples from patients with HS (n=40), probable HS (n=21), auto-immune hemolytic anemia (n=7), and other pathologies (n=37) were studied. Daily controls were run in parallel with patient samples. Results were expressed as percent of change compared to mean of controls.

Results:

Analytical performances showed an inter-assay variability between 0.2% and 3%. Samples were stable for 48–72 h depending of temperature storage and anticoagulant used. The following diagnostic cut-offs were established for HS: an increase of more than 21.5% for the osmolality point at the minimal elongation index (O min), a decrease of more than 8.5% for the maximal elongation index (EI max), and a decreased area under the curve (AUC) of more than 18.5% compared to the mean of controls.

Conclusions:

As the previous instrument, the next-generation ektacytometer is an efficient tool for laboratory diagnosis of HS. Sample stability and standardized reporting of results allow inter-laboratory exchange and comparison. The most useful parameters for HS diagnosis were AUC, EI max, and O min; unfortunately, this method does not differentiate between HS and auto-immune hemolytic anemia (AIHA), but it distinguishes HS from other hereditary membrane pathologies. It can thus be considered as an intermediate step between screening and diagnostic tests.

Keywords: diagnosis; hereditary spherocytosis; Osmoscan; osmotic gradient ektacytometry; red blood cells

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in thestudy design; in the collection, analysis, and interpretationof data; in the writing of the report; or in the decision tosubmit the report for publication.

References

1. Eber SW, Pekrun A, Neufeldt A, Schröter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol 1992;64:88–92.10.1007/BF01715351Search in Google Scholar PubMed

2. Tse WT, Lux SE. Red blood cell membrane disorders. Br J Haematol 1999;104:2–13.10.1111/j.1365-2141.1999.01130.xSearch in Google Scholar PubMed

3. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis-2011 update. Br J Haematol 2012;156:37–49.10.1111/j.1365-2141.2011.08921.xSearch in Google Scholar PubMed

4. Lazarova E, Pradier O, Cotton F, Gulbis B. Automated reticulocyte parameters for hereditary spherocytosis screening. Ann Hematol 2014;93:1809–18.10.1007/s00277-014-2127-8Search in Google Scholar PubMed

5. Mullier F, Lainey E, Fenneteau O, Da Costa L, Schillinger F, Bailly N, et al. Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study. Ann Hematol 2011;90:759–68.10.1007/s00277-010-1138-3Search in Google Scholar PubMed

6. Parpart AK, Lorenz PB, Parpart ER, Gregg JR, Chase AM. The osmotic resistance (fragility) of human red cells. J Clin Invest 1947;26:636–40.10.1172/JCI101847Search in Google Scholar PubMed PubMed Central

7. Gottfried EL, Robertson NA. Glycerol lysis time of incubated erythrocytes in the diagnosis of hereditary spherocytosis. J Lab Clin Med 1974;84:746–51.Search in Google Scholar

8. Zanella A, Izzo C, Rebulla P, Zanuso F, Perroni L, Sirchia G. Acidified glycerol lysis test: a screening test for spherocytosis. Br J Haematol 1980;45:481–6.10.1111/j.1365-2141.1980.tb07167.xSearch in Google Scholar PubMed

9. Vettore L, Zanella A, Molaro GL, De Matteis MC, Pavesi M, Mariani M. A new test for the laboratory diagnosis of spherocytosis. Acta Haematol 1984;72:258–63.10.1159/000206398Search in Google Scholar PubMed

10. Streichman S, Gescheidt Y, Tatarsky I. Hypertonic cryohemolysis: a diagnostic test for hereditary spherocytosis. Am J Hematol 1990;35:104–9.10.1002/ajh.2830350208Search in Google Scholar PubMed

11. King MJ, Behrens J, Rogers C, Flynn C, Greenwood D, Chambers K. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000;111:924–33.Search in Google Scholar

12. Hunt L, Greenwood D, Heimpel H, Noel N, Whiteway A, King MJ. Toward the harmonization of result presentation for the eosin-5′-maleimide binding test in the diagnosis of hereditary spherocytosis. Cytometry B Clin Cytom 2015;88:50–7.10.1002/cytob.21187Search in Google Scholar PubMed

13. Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti L, Cortelezzi A, et al. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica 2012;97:516–23.10.3324/haematol.2011.052845Search in Google Scholar

14. King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, et al; International Council for Standardization in Haematology. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 2015;37:304–25.10.1111/ijlh.12335Search in Google Scholar

15. van Wijk R, van der Zwaag B, Vogel MJ, Elferink MG, Nijman IJ, Cuppen E, et al. Next generation sequencing in the diagnosis of red blood cell membrane disorders [abstract]. Haematologica 2013;98(s1):420.Search in Google Scholar

16. Clark MR, Mohandas N, Shohet SB. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood 1983;61:899–910.10.1182/blood.V61.5.899.899Search in Google Scholar

17. Hardeman MR, Goedhart PT, Dobbe JGG, Letting KP. Laser-assisted optical rotational cell analyzer (L.O.R.C.A); I. A new instrument for measurement of various structural hemorheological parameters. Clin Hemorheol 1994;14:605–18.Search in Google Scholar

18. Klarik Z, Kiss F, Miko I, Nemeth N. Aorto-porto-caval micro-rheological differences of red blood cells in laboratory rats: further deformability and ektacytometrial osmoscan data. Clin Hemorheol Microcirc 2013;53:217–29.10.3233/CH-2012-1539Search in Google Scholar

19. Nemeth N, Kiss F, Miszti-Blasius K. Interpretation of osmotic gradient ektacytometry (osmoscan) data: a comparative study for methodological standards. Scand J Clin Lab Invest 2015;75: 213–22.10.3109/00365513.2014.993695Search in Google Scholar

20. King MJ, Zanella A. Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol 2013;35:237–43.10.1111/ijlh.12070Search in Google Scholar

21. Da Costa L, Galimand J, Fenneteau O, Mohandas N. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev 2013;27:167–78.10.1016/j.blre.2013.04.003Search in Google Scholar

22. Da Costa L, Suner L, Galimand J, Bonnel A, Pascreau T, Couque N, et al. Diagnostic tool for red blood cell membrane disorders: assessment of a new generation ektacytometer. Blood Cells Mol Dis 2016;56:9–22.10.1016/j.bcmd.2015.09.001Search in Google Scholar

23. Hibbert DB. Method Validation. Oxford: Elsevier, 2005.Search in Google Scholar

24. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996;128:259–69.10.1016/S0022-2143(96)90027-XSearch in Google Scholar

25. Reliene R, Mariani M, Zanella A, Reinhart WH, Ribeiro ML, del Giudice EM, et al. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood 2002;100:2208–15.10.1182/blood.V100.6.2208Search in Google Scholar

26. Deuel JW, Lutz HU, Misselwitz B, Goede JS. Asymptomatic elevation of the hyperchromic red blood cell subpopulation is associated with decreased red cell deformability. Ann Hematol 2012;91:1427–34.10.1007/s00277-012-1467-5Search in Google Scholar PubMed

27. Katyukhin LN. A method for evaluation of membrane permeability for water by the erythrocyte osmotic deformability profiles. Bull Exp Biol Med 2014;157:116–8.10.1007/s10517-014-2505-1Search in Google Scholar PubMed

Supplemental Material:

The online version of this article (DOI: 10.1515/cclm-2016-0290) offers supplementary material, available to authorized users.

Received: 2016-4-10
Accepted: 2016-7-12
Published Online: 2016-8-25
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Targeting errors in microbiology: the case of the Gram stain
  4. Time for a holistic approach and standardization education in laboratory medicine
  5. Reviews
  6. Serum uric acid levels and risk of prehypertension: a meta-analysis
  7. Lactic acidosis: an update
  8. Mini Review
  9. Progress and impact of enzyme measurement standardization
  10. Opinion Paper
  11. Critical comments to a recent EFLM recommendation for the review of reference intervals
  12. IFCC Paper
  13. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  14. Genetics and Molecular Diagnostics
  15. Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Risk analysis of the preanalytical process based on quality indicators data
  18. Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
  19. Looking beyond linear regression and Bland-Altman plots: a comparison of the clinical performance of 25-hydroxyvitamin D tests
  20. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
  21. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
  22. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
  23. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
  24. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  25. Cancer Diagnostics
  26. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma
  27. Cardiovascular Diseases
  28. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
  29. Infectious Diseases
  30. Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
  31. Diabetes
  32. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients
  33. Corrigendum
  34. EFLM Recommendation
  35. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories
  36. Letters to the Editor
  37. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  38. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
  39. Mixing studies for abnormal coagulation screen – the current trend
  40. Identification of 5-fluorocytosine as a new interfering compound in serum capillary zone electrophoresis
  41. How to define reference intervals to rule in healthy individuals for clinical trials?
  42. Evaluation of the performance of INDEXOR® in the archive unit of a clinical laboratory: a step to Lean laboratory
  43. Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome
  44. Analysis of hemolysis, icterus and lipemia in arterial blood gas specimens
  45. Comparison of three routine insulin immunoassays: implications for assessment of insulin sensitivity and response
https://doi.org/10.1515/cclm-2016-0290
Keywords for this article
diagnosis; hereditary spherocytosis; Osmoscan; osmotic gradient ektacytometry; red blood cells

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Targeting errors in microbiology: the case of the Gram stain
  4. Time for a holistic approach and standardization education in laboratory medicine
  5. Reviews
  6. Serum uric acid levels and risk of prehypertension: a meta-analysis
  7. Lactic acidosis: an update
  8. Mini Review
  9. Progress and impact of enzyme measurement standardization
  10. Opinion Paper
  11. Critical comments to a recent EFLM recommendation for the review of reference intervals
  12. IFCC Paper
  13. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  14. Genetics and Molecular Diagnostics
  15. Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Risk analysis of the preanalytical process based on quality indicators data
  18. Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
  19. Looking beyond linear regression and Bland-Altman plots: a comparison of the clinical performance of 25-hydroxyvitamin D tests
  20. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
  21. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
  22. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
  23. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
  24. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  25. Cancer Diagnostics
  26. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma
  27. Cardiovascular Diseases
  28. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
  29. Infectious Diseases
  30. Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
  31. Diabetes
  32. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients
  33. Corrigendum
  34. EFLM Recommendation
  35. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories
  36. Letters to the Editor
  37. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  38. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
  39. Mixing studies for abnormal coagulation screen – the current trend
  40. Identification of 5-fluorocytosine as a new interfering compound in serum capillary zone electrophoresis
  41. How to define reference intervals to rule in healthy individuals for clinical trials?
  42. Evaluation of the performance of INDEXOR® in the archive unit of a clinical laboratory: a step to Lean laboratory
  43. Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome
  44. Analysis of hemolysis, icterus and lipemia in arterial blood gas specimens
  45. Comparison of three routine insulin immunoassays: implications for assessment of insulin sensitivity and response
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0290/html
Scroll to top button